購(gòu)物車
幫助
021-54845833/15800441009
中文名稱：小鼠抗NAPSA單克隆抗體
|
Background: |
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus. [provided by RefSeq, Jul 2008]. |
|
Applications: |
IHC, IF |
|
Name of antibody: |
NAPSA |
|
Immunogen: |
Fusion protein of human NAPSA |
|
Full name: |
napsin A aspartic peptidase (NAPSA) |
|
Synonyms: |
KAP; Kdap; NAP1; NAPA; SNAPA |
|
SwissProt: |
O96009 |
|
IHC positive control: |
adenocarcinoma of human ovary tissue and carcinoma of human prostate tissue |
|
IHC Recommend dilution: |
30-150 |
|
IF Positive control: |
TT cells |
|
IF Recommended dilution: |
50-100 |
